Effect of Rosuvastatin on Left Ventricular Remodeling
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the the effect of the HMG-CoA reductase inhibitor
Rosuvastatin on left ventricular remodeling in patients with dilated cardiomyopathy.